Senior insider sale
Chief Financial Officer at CADRENAL THERAPEUTICS, INC. — senior position signals high conviction
$302.6K
21.60K shares
SZOT MATTHEW K plans to sell 21.60K shares of CADRENAL THERAPEUTICS, INC. valued at approximately $302.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Founders Shares
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/17/2022 | Founders Shares N/A | 1.80K | — |
| Total | 1.80K | ||
Completed
Units to sell
1.80K
Market value
$25.3K
Units to sell
1.69K
Market value
$23.7K
Units to sell
107.00
Market value
$1.5K
Units to sell
1.70K
Market value
$23.8K
Units to sell
100.00
Market value
$1.4K
Units to sell
10.90K
Market value
$153.2K
Units to sell
1.50K
Market value
$21.0K
Units to sell
400.00
Market value
$5.6K
Units to sell
1.60K
Market value
$22.4K
Planned — Approximate Date
Units to sell
1.80K
Market value
$24.8K
Units
21.60K
Value
$302.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/13/2025 | 1.80K | $25.3K | — | Completed |
10/9/2025 | 1.69K | $23.7K | — | Completed |
10/6/2025 | 107.00 | $1.5K | — | Completed |
10/1/2025 | 1.70K | $23.8K | — | Completed |
9/29/2025 | 100.00 | $1.4K | — | Completed |
9/25/2025 | 10.90K | $153.2K | — | Completed |
9/24/2025 | 1.50K | $21.0K | — | Completed |
8/28/2025 | 400.00 | $5.6K | — | Completed |
8/27/2025 | 1.60K | $22.4K | — | Completed |
| Planned — Approximate Date | ||||
10/24/2025 | 1.80K | $24.8K | NASDAQ | Planned |
| Total | 21.60K | $302.6K | ||